Preclinical evaluation of [ 111 In]-DOTA-trastuzumab for clinical trials

AmirReza Jalilian, Mohammad Mirzaii, Gholamreza Aslani, Saeed Rajabifar, Sedigheh Moradkhani, Mehraban Pouladi, Behrouz Alirezapour
  • Journal of Cancer Research and Therapeutics, January 2014, Medknow
  • DOI: 10.4103/0973-1482.131434

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.4103/0973-1482.131434

The following have contributed to this page: Prof Amir R Jalilian